<?xml version="1.0" encoding="UTF-8"?>
<ref id="B9-pharmaceutics-10-00039">
 <label>9.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Davis</surname>
    <given-names>N.L.</given-names>
   </name>
   <name>
    <surname>Grieder</surname>
    <given-names>F.B.</given-names>
   </name>
   <name>
    <surname>Smith</surname>
    <given-names>J.F.</given-names>
   </name>
   <name>
    <surname>Greenwald</surname>
    <given-names>G.F.</given-names>
   </name>
   <name>
    <surname>Valenski</surname>
    <given-names>M.L.</given-names>
   </name>
   <name>
    <surname>Sellon</surname>
    <given-names>D.C.</given-names>
   </name>
   <name>
    <surname>Charles</surname>
    <given-names>P.C.</given-names>
   </name>
   <name>
    <surname>Johnston</surname>
    <given-names>R.E.</given-names>
   </name>
  </person-group>
  <article-title>A molecular genetic approach to the study of Venezuelan equine encephalitis virus pathogenesis</article-title>
  <source>Arch. Virol. Suppl.</source>
  <year>1994</year>
  <volume>9</volume>
  <fpage>99</fpage>
  <lpage>109</lpage>
  <?supplied-pmid 8032286?>
  <pub-id pub-id-type="pmid">8032286</pub-id>
 </element-citation>
</ref>
